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Abstract
 
We previously reported that central–memory T cells (T
 
CM
 
 cells), which express lymph node
homing receptors CCR7 and CD62L, are largely devoid of effector functions but acquire char-
acteristics of effector–memory T cells (T
 
EM 
 
cells) (i.e., CCR7
 
  
 
T helper [Th]1 or Th2 cells) after
stimulation with T cell receptor agonists or homeostatic cytokines. Here we show that three
chemokine receptors identify functional subsets within the human CD4
 
  
 
T
 
CM 
 
cell pool. T
 
CM
 
cells expressing CXCR3 secreted low amounts of interferon 
 
 
 
, whereas CCR4
 
  
 
T
 
CM 
 
cells pro-
duced some interleukin (IL)-4, but not IL-5. In response to IL-7 and IL-15, CXCR3
 
  
 
T
 
CM 
 
and
CCR4
 
  
 
T
 
CM 
 
cells invariably generated fully differentiated CCR7
 
  
 
Th1 and Th2 cells, respectively,
suggesting that they represent pre-Th1 and pre-Th2 cells. Conversely, CXCR5
 
  
 
T
 
CM 
 
cells
lacking CXCR3 and CCR4 remained nonpolarized and retained CCR7 and CD62L expression
upon cytokine-driven expansion. Unlike naive cells, all memory subsets had a low T cell re-
ceptor rearrangement excision circle content, spontaneously incorporated bromodeoxyuridine
ex vivo, and contained cells specific for tetanus toxoid. Conversely, recall responses to cyto-
megalovirus and vaccinia virus were largely restricted to CXCR3
 
  
 
T
 
CM 
 
and T
 
EM 
 
cells. We conclude
that antigen-specific memory T cells are distributed between T
 
EM 
 
cells and different subsets of
T
 
CM 
 
cells. Our results also explain how the quality of primary T cell responses could be maintained
by T
 
CM 
 
cells in the absence of antigen.
Key words: T cell subsets • memory maintenance • cytokines • differentiation • 
chemokine receptors
 
Introduction
 
Upon recognition of antigenic peptides on DCs, naive T
lymphocytes proliferate and differentiate into a variety of
effector cells depending on the stimulatory conditions and
cytokine milieu (1, 2). Accumulating evidence indicates
that during the T cell differentiation process, effector func-
tions and homing potentials are coordinately regulated (3).
For instance, developing Th1 cells acquire the capacity to
produce IFN-
 
  
 
and expression of chemokine receptors
such as CCR5, CXCR3, and CXCR6 that drive them to
sites of delayed-type hypersensitivity reactions. Conversely,
developing Th2 cells acquire the capacity to produce IL-4
and express CCR3, CCR4, CCR8, and the prostaglandin
D2 chemoattractant receptor CRTh2 (4–7), which are re-
quired to migrate at sites of allergic reactions (6, 8, 9).
Expression of the lymph node homing receptors CCR7
and CD62L (10, 11) has been used to define subsets of human
memory T cells with distinct functional properties. T cells
within the CCR7
 
  
 
“central–memory” T cell (T
 
CM 
 
cell)
cell subset show hypo-acetylated cytokine genes and have
no or low effector functions, but efficiently differentiate to
Th1 or Th2 effector cells after TCR stimulation in the
presence of IL-12 or IL-4, respectively (12–14). In contrast, T
cells of the CCR7
 
  
 
“effector–memory” T cell (T
 
EM 
 
cell)
subset show polarized cytokine gene acetylation patterns in
vivo and rapidly produce high amounts of IFN-
 
  
 
and IL-4
upon antigenic stimulation (12–14). It has been proposed
that in secondary immune responses, T
 
CM 
 
cells generate
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new waves of effector cells in antigen-draining lymph
nodes, whereas T
 
EM 
 
cells provide immediate protection
against invading pathogens in peripheral tissues (3, 14).
The maintenance of T cell memory is controlled by cy-
tokines that promote cell survival and slow homeostatic
proliferation (15). In particular, IL-7 and IL-15 have been
shown to regulate mouse CD8
 
  
 
memory T cell survival
and self-renewal in the absence of antigen (16, 17), whereas
naive and CD4
 
  
 
memory cells require IL-7 and TCR
ligands (16, 18, 19), but do not respond to IL-15 (17).
Conversely, human CD4
 
  
 
memory T cells proliferate in
response to IL-15 in a TCR-independent fashion and with
slow kinetics (20, 21), suggesting different roles for IL-15
in mouse and human CD4
 
  
 
memory T cell homeostasis.
Notably, T
 
CM 
 
cells proliferating in response to IL-7 and IL-
15 differentiate and generate Th1 and Th2 effector cells
(21), but how uncommitted T
 
CM 
 
cells proliferating in the
absence of antigen could maintain the quality of the pri-
mary response remained unclear.
The existence of T
 
CM 
 
and T
 
EM 
 
cell subsets has also been
documented in mice (22, 23). In this experimental system,
it has been possible to directly examine the kinetics of
memory cell generation and the capacity of effector and
memory subsets to reconstitute long-term memory (24),
and there is growing evidence that T
 
CM 
 
cells have higher
reconstitution potential (24, 25). In particular, effector Th1
cells, defined by their secretion of IFN-
 
 
 
, were found to be
short-lived and unable to reconstitute T cell memory. In
contrast, a population of activated Th1 lineage cells, which
did not secrete IFN-
 
  
 
after primary antigenic stimulation,
persisted for several months in vivo and developed the ca-
pacity to secrete IFN-
 
  
 
upon subsequent stimulation (26).
Since the first description of T
 
CM 
 
and T
 
EM 
 
cells, it was
evident that other chemokine receptors, as well as adhesion
and costimulatory molecules, are expressed on different
fractions of T
 
CM 
 
cells (12, 14). Heterogeneity of human
CD4
 
  
 
T
 
CM 
 
cells has further been documented using CXCR5,
the receptor for CXCL13, a chemokine expressed in B cell
follicles (27, 28). CXCR5
 
  
 
T
 
CM 
 
cells lacked effector func-
tions and cells specific for tetanus toxoid (TT), but con-
tained residual T cell receptor rearrangement excision
circles (TRECs), suggesting that they represent recently
activated cells (29–31). Conversely, other recent studies
claimed that both T
 
CM 
 
and T
 
EM 
 
cells possess high levels of
effector functions, and that consequently neither CCR7
nor CXCR5 expression identify nonpolarized CD4
 
  
 
mem-
ory T cells (9, 32–35). Understanding T
 
CM 
 
cell differen-
tiation stage and potential is of importance for the ho-
meostatic maintenance of memory T cells and for the
conservation of T cell polarization in secondary responses.
Here we report that CXCR3 and CCR4 identify two
novel subsets of pre-Th1 and pre-Th2 cells within T
 
CM
 
cells. These cells possessed low IFN-
 
 
 
–
 
 
 
or IL-4–producing
capacities when compared with CXCR3
 
  
 
and CCR4
 
 
 
T
 
EM 
 
cells and spontaneously differentiated to Th1 and Th2
effector cells in response to homeostatic cytokines IL-7 and
IL-15 independently of conventional Th1 or Th2 cell–induc-
ing stimuli. In contrast, T
 
CM 
 
cells lacking CXCR3 or CCR4
and expressing CXCR5 were nonpolarized cells whose dif-
ferentiation to Th1 or Th2 cells is dependent on TCR trig-
gering and signaling by polarizing cytokines.
 
Materials and Methods
 
Cell Culture.
 
PBMCs were isolated from buffy-coated blood
from healthy donors. Monocytes were depleted by adhesion for
30 min and CD4
 
  
 
T cells were isolated by negative selection
with magnetic beads using Automacs (Miltenyi Biotec). Memory
T cells were isolated by further depletion of naive T cells with
anti-CD45RA beads (Miltenyi Biotec). Memory T cell subpopu-
lations were purified to 
 
 
 
95% by cell sorting after five-color
staining as follows: anti-CXCR5 (R&D Systems) followed by
anti-IgG2b PE (Biosystems), anti-CCR7 (R&D Systems) fol-
lowed by anti-IgG2a FITC (Biosystems), and anti-CXCR3 Cy-
Chrome, anti-CD45RA APC, and anti-CCR4 biotin followed
by streptavidin-APC-Cy7 (BD Biosciences). Labeling of T cells
with carboxyfluorescein succinimidyl ester (CFSE) was performed
as described previously (21). Monocytes were purified by positive
selection with anti-CD14 beads (Miltenyi Biotec). For DC dif-
ferentiation, CD14
 
  
 
cells were cultured for 4 d in complete me-
dium (RPMI 1640 supplemented with 2 mM glutamine, 1%
nonessential amino acids, 1% sodium pyruvate, 50 
 
 
 
g/ml kana-
mycin, 50 U/ml penicillin, and 50 
 
 
 
g/ml streptomycin; GIBCO
BRL) containing 10% FCS (Hyclone), 50 ng/ml granulocyte/
macrophage colony-stimulating factor (Novartis), and 1,000
U/ml IL-4. The DCs obtained were stimulated for 24 h with 100
ng/ml lipopolysaccharide (
 
Salmonella
 
 
 
abortus equi
 
; Sigma-Aldrich)
and pulsed for 30 min with 100 ng/ml toxic shock syndrome
toxin (TSST). CFSE-labeled 5 
 
  
 
10
 
4 
 
T cells were cultured with
TSST-pulsed DCs in flat-bottom wells at a 5:1 ratio, and recom-
binant cytokines were used at either 25 ng/ml (IL-7 and IL-15;
R&D Systems), 10 ng/ml (TNF, IL-6, IL-10, IL-4, and IL-12;
BD Biosciences), or 1,000 U/ml (IL-2; Roche), whereas neutral-
izing antibodies to IL-4 and IL-12 (BD Biosciences) were used at
2 
 
 
 
g/ml.
 
ELISA, Intracellular Cytokine Staining, and IFN-
 
  
 
Secretion Assay.
 
Cytokine-producing capacity of FACS-purified subsets was as-
sessed after stimulation of purified cell populations at 5 
 
  
 
10
 
4
 
/100
 
 
 
l for 24 h with 50 nM phorbol-12-13-dibutyrate (PdBu) and 0.5
 
 
 
g/ml ionomycin, or in wells coated with 2 
 
 
 
g/ml each of anti-
CD3 (clone TR66) and anti-CD28 antibodies (BD Biosciences).
Cytokine concentrations of supernatants were then assessed by
ELISA according to a standard protocol and analyzed with the
Softmax program. Intracellular IFN-
 
  
 
was detected after stimulat-
ing cells in the presence of 10 
 
 
 
g/ml brefeldin A (Sigma-Aldrich)
for the last 2 h and after fixation with paraformaldehyde and per-
meabilization with saponin. After saturation of nonspecific bind-
ing sites with 10% FCS, cells were incubated with APC-labeled
antibody to IFN-
 
  
 
and PE-labeled antibody to IL-2 or IL-4 (BD
Biosciences), washed, and analyzed by flow cytometry on a
FACSCalibur with CELLQuest software (Becton Dickinson). To
sort live IFN-
 
 
 
–producing cells, we stimulated cells for 60 h with
25 ng/ml cytokines (IL-7, IL-15, IL-12, TNF-
 
 
 
, and IL-18), and
IFN-
 
 
 
–producing cells were identified with an IFN-
 
  
 
secretion
assay kit (Miltenyi Biotec) and purified by cell sorting.
 
Recall Responses.
 
PBMCs from 50 ml of fresh blood from
healthy volunteers were prepared, monocytes were isolated and
either incubated for 16 h with a replication-deficient vaccinia vi-
rus (VV; provided by G. Sutter, Institute for Virology, Munich, 
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Germany) or left untreated. 5 
 
  
 
10
 
4 
 
monocytes were then irradi-
ated and incubated in the absence or presence of 1 
 
 
 
g/ml TT or
2.5 
 
 
 
g of an extract of CMV-derived proteins (provided by R.
Campanelli, University of Pavia, Pavia, Italy) with purified T cell
subsets at a 1:1 ratio in U-bottom wells in complete medium con-
taining 5% human serum. On days 5 and 7, cells were stained for
CD14 and CD4, and CFSE dilution of CD4
 
  
 
CD14
 
  
 
viable cells
was assessed by flow cytometry. On day 5, cells had not yet di-
luted CFSE completely, and the precursor frequency of antigen-
specific cells could therefore be calculated as described previously
(36). In some experiments, the presence of pathogen-specific cells
was confirmed by restimulating cells with autologous monocytes
treated as described above followed by assessment of cytokine pro-
duction of proliferating T cells by intracellular staining.
 
Ex Vivo Bromodeoxyuridine (BrdU) Labeling.
 
The assay was
performed as described previously (25). In brief, fresh PBMCs
were cultured with 10 
 
 
 
g/ml BrdU (Sigma-Aldrich) for 16 h.
CD4
 
  
 
cells were then positively selected with anti-CD4 mag-
netic beads and stained for CD45RA and chemokine receptor
expression. Cells were then fixed, permeabilized, treated with
DNase (Boehringer), stained with FITC-labeled anti-BrdU anti-
body (Becton Dickinson), and analyzed by flow cytometry.
 
Quantitative PCR of TRECs.
 
Memory CD4
 
  
 
T cells were
isolated by MACS as described above, stained for CD4,
CD45RO, CCR7, and CXCR5, and sorted to 
 
 
 
99.9% purity.
Quantification of signal joint TRECs in sorted CD4
 
  
 
T cell sub-
sets was performed by real-time quantitative PCR with the 5
 
 
 
nuclease (TaqMan) assay using an ABI 7700 sequence detector
(Applied Biosystems). As described previously (37), 1–2 
 
  
 
10
 
5
 
cells were lysed in 10 mM Tris, pH8, containing 100 
 
 
 
g/ml of
proteinase K (GIBCO BRL) for 2 h at 56
 
 
 
C, and then for 15 min
at 95
 
 
 
C. PCR reaction of lysates was performed with 500 nM of
primers (CACATCCCTTTCAACCATGCT and GCCAGCT-
GCAGGGTTTAGG) and 125 nM of probe FAM-ACAC-
CTCTGGTTTTTGTAAAGGTGCCCACT-TAMRA. PCR
conditions were as follows: 1 cycle of 2 min at 50
 
 
 
C, 1 cycle of
10 min at 95
 
 
 
C, followed by 40 cycles of 30 s at 95
 
 
 
C, and 1 min
at 65
 
 
 
C. Levels of DNA were standardized by normalizing with
18S rRNA sequences.
 
Results
 
Subsets of Human CD4
 
  
 
T
 
CM 
 
Cells Identified by Expression
of CXCR5, CXCR3, and CCR4.
 
Purified human CD4
 
 
 
T cells were analyzed for chemokine receptor expression by
five-color staining. CD45RA
 
  
 
cells expressed CCR7, but
were largely negative for the other chemokine receptors,
consistent with the view that they are predominantly anti-
gen-inexperienced “naive” T cells (not depicted). Con-
versely, the following three main subsets could be identified
in CD45RA
 
  cells according to CCR7 and CXCR5
expression: CXCR5  CCR7  cells (CXCR5  TCM),
CXCR5  CCR7  cells (CXCR5  TCM), and CXCR5 
CCR7  cells (TEM; Fig. 1 A). Within these main subsets,
staining with antibodies to CXCR3 and CCR4 revealed
further heterogeneity (Fig. 1 B). CXCR3 and CCR4 were
expressed on different populations of TEM cells, which
contain Th1 and Th2 effector cells (4, 9, 38). However,
CXCR3 and CCR4 were also expressed on some TCM cells,
especially within the CXCR5  subset (Fig. 1 B). Thus, the
following four major subsets of TCM cells were identified: (a)
CXCR3  CCR4  CXCR5  TCM cells (“CXCR5  TCM”),
(b) CXCR3  CCR4  CXCR5  TCM cells (“    TCM”), (c)
CXCR5  CXCR3  CCR4  TCM cells (“CXCR3  TCM”),
and (d) CXCR5  CCR4  CXCR3  TCM cells (“CCR4 
TCM”). Mean values   standard deviations of the four sub-
sets in four healthy donors were 11   5%, 18   10%, 17  
8%, and 17   12%, respectively.
Because CXCR3 and CCR4 have been associated with
differentiated Th1 and Th2 cells (7, 38), we analyzed ex-
pression of other surface markers that are acquired or lost
Figure 1. Expression of chemokine receptors defines
CD4  TCM cell subsets with distinct replicative potentials.
Purified CD4  T cells were stained with antibodies specific
for CXCR5, CCR7, CXCR3, CCR4, and CD45RA,
and analyzed by five-color flow cytometry. (A) CCR7 and
CXCR5 expression of CD45RA  cells of one representative
donor out of four. (B) CXCR5  TCM, CXCR5  TCM, and
TEM cells were analyzed for CXCR3 and CCR4 expression.
Percentages indicate the mean frequency of subsets in the
memory pool of five healthy donors. (C) Purified, CFSE-
labeled CD4  T cell subsets were stimulated with IL-7 and
IL-15, or TSST-loaded DCs for 7 d. CFSE profiles of viable
(propidium iodide ) cells were analyzed by flow cytome-
try. Numbers in the top row indicate the percentage of
dividing  cells and numbers in parenthesis indicate the
mean division number. Numbers in the bottom row indi-
cate the fraction of TSST-responsive TCR V 2  cells.
One representative donor out of four is shown.Chemokine Receptor Expression Identifies Central Memory T Cell Subsets 728
with T cell differentiation (12, 17, 39; Table I). As
expected, naive T cells expressed uniformly CD27 and
CD62L, but not the IL-2/15R  chain (CD122), whereas
most TEM cells had lost CD27 and CD62L expression, but
were CD122 . CXCR5  TCM cells had a phenotype simi-
lar to naive cells, whereas CXCR5  TCM cells expressed in-
termediate levels of CD27, CD62L, and CD122. In partic-
ular, CXCR3  TCM cells were CD122  and had partially
lost CD62L expression, consistent with a more differenti-
ated phenotype. The differences in CD122 expression
were functionally relevant because they closely correlated
with proliferation in response to IL-7 and IL-15 (Fig. 1 C,
top), being low in naive cells and CXCR5  TCM cells, in-
termediate in CCR4  TCM cells and  / TCM cells, and high
in CXCR3  TCM and TEM cells.
We then compared the expansion potential of purified
CFSE-labeled CD4  naive and memory T cell subsets after
TCR stimulation with TSST-loaded DCs because replica-
tive capacity diminishes with T cell differentiation (25, 40).
Proliferation and accumulation was high in naive cells,
CXCR5  TCM  cells, and  / TCM  cells, intermediate in
CCR4  and CXCR3  TCM cells, and low in TEM cells (Fig.
1 C, bottom). As reported for the CD8 compartment (25),
the reduced accumulation of TEM cells was associated with
a high rate of apoptosis (Table I). Similar results were ob-
tained upon stimulation with anti-CD3 and anti-CD28 an-
tibodies (not depicted).
Together, these results show that subsets of CD4  TCM
cells identified by CXCR5, CXCR3, and CCR4 expres-
sion differ in their proliferative response to cytokines and
TCR ligands, and suggest that CXCR5  TCM cells and
 / TCM cells are at an early stage of memory cell differenti-
ation, whereas CCR4  and CXCR3  TCM cells have char-
acteristics of more mature cell types.
CXCR3 and CCR4 Identify TCM Cells with Low IFN- –
and IL-4–producing Capacities. Next, we analyzed effector
cytokine–producing capacities of TCM and TEM cell sub-
sets. Total TCM and TEM cell populations were sorted for
CXCR3 and CCR4 expression, stimulated with PdBu and
ionomycin, and secreted cytokines were quantified by
ELISA (Fig. 2 A). TCM cells lacking CXCR3 and CCR4
failed to produce IFN- , IL-4, and IL-5, whereas double
negative cells in the TEM subset produced all three cyto-
kines. Consistent with the role of CXCR3 and CCR4 as
Th1 and Th2 cell markers, CXCR3-expressing cells pro-
duced predominantly IFN- , whereas CCR4  cells pro-
Table I. Expression of CD27, CD62L, and IL-2/IL-15R  Chain (CD122) on Naive T Cells and Memory T Cell Subsetsa
TCM
CXCR5  CXCR5 
TN     CXCR3     CCR4  TEM
CD27  (%)b 99   1 98   2 76   9 83   9 72   17 40   8
CD62Lhi (%)b 99   1 89   5 55   15 84   8 79   9 23   12
CD122 (MFI)c 1   13     28     36     25     2 10   3
PI  (%)d 3   27     4 17   99     5 15   8 25   10
aMean   standard deviation of four healthy donors.
bPercent of positive cells.
cMean fluorescence intensity.
dPropidium iodide  cells after stimulation for 3 d with DC  TSST.
Figure 2. Ex vivo cytokine-producing capacities of CD4  memory T
cell subsets. (A) Purified CD4  TCM and TEM cell subsets were stimulated
with PdBu and ionomycin for 24 h and supernatants were analyzed for
IFN-  (diluted 1:4, white bars), IL-4 (black bars), and IL-5 (gray bars) by
ELISA. Stimulation with anti-CD3 and anti-CD28 antibodies gave similar
results (not depicted). Shown is the mean of four experiments with cells
from different donors. (B) CXCR3  CD4  T cells were sorted for CCR7
and CD62L expression as indicated and IFN-  production was assessed as
described above. The mean of three independent experiments with three
different donors is shown.Rivino et al. 729
duced mainly type 2 cytokines. However, CXCR3  TCM
and CCR4  TCM cells produced less effector cytokines
than the corresponding TEM cell subset, and IL-5 produc-
tion was entirely restricted to TEM cells. Similar results were
obtained when CXCR5  TCM and CXCR5  TCM cell
subsets were analyzed separately (not depicted). Because
CXCR3  TCM cells contained a considerable fraction of
CD62L  cells (Table I), we further analyzed IFN- –pro-
ducing capacity of CXCR3  TCM and TEM cells according
to CD62L expression (Fig. 2 B). CXCR3  TCM cells ex-
pressing CD62L produced only low amounts of IFN- ,
whereas CXCR3  TCM  cells lacking CD62L produced
high levels of IFN-  comparable to TEM cells. Thus, IFN- 
production among CCR7  cells is largely restricted to a
TEM cell–like subset of CD62L  CXCR3  cells. Collec-
tively, these results show that CXCR3 and CCR4 identify
cells in the TCM cell pool that are nonpolarized or produce
low levels of IFN-  or IL-4.
Cytokine-stimulated CXCR3  and CCR4  TCM Cells Dif-
ferentiate to Th1 and Th2 Cells. We previously showed
that some cytokine-stimulated TCM cells spontaneously dif-
ferentiate to Th1 or Th2 cells, whereas naive cells require
TCR ligands or inflammatory cytokines for differentiation
(21, 41). To understand whether the subsets defined by
CXCR5, CXCR3, and CCR4 could discriminate cells
with predetermined fates, we induced proliferation of puri-
fied CD4  T cell subsets by either TSST-loaded DCs or
IL-7 and IL-15 (Fig. 3 A). Because memory subsets showed
different proliferative responses to IL-7 and IL-15 (Fig. 1
C), and acquisition of effector cytokine–producing capaci-
ties progressively increases with division number (42, 43),
analysis was performed by gating on cells that had per-
formed the same number of divisions (cytokines: 4; TSST:
 7). Under both conditions of stimulation, CXCR5  TCM
cells that lacked CXCR3 and CCR4 expression remained
nonpolarized, whereas  / TCM cells generated some Th1
and Th2 cells and acquired CXCR3 and CCR4 on a frac-
tion of cells at the same time (Fig. 3 C). Cytokine-stimu-
lated CXCR5  TCM cells progressively lost CXCR5 ex-
pression, but homogeneously maintained high levels of
CCR7 and CD62L, whereas a fraction of CXCR5  TCM
cells progressively lost CCR7 and CD62L expression, thus
acquiring the phenotype of TEM cells (Fig. 3 B). Notably,
TEM cells remained CCR7  and maintained high effector
functions under these conditions.
When CXCR3  TCM and CCR4  TCM cells were
expanded with homeostatic cytokines, they maintained
CXCR3 and CCR4 expression (Fig. 3 C) and spontane-
ously differentiated into Th1 and Th2 cells, respectively
(Fig. 3 A). Thus, CCR4  TCM cells produced high levels of
IL-4 and also secreted IL-5 (not depicted), a type 2 cyto-
kine produced exclusively by TEM cells (Fig. 2 A). More-
over, the amount of IFN-  produced by CXCR3  TCM
cells stimulated with IL-7 and IL-15 was comparable to
that produced by CXCR3  TEM cells ex vivo, and a frac-
tion of CXCR3  TCM cells acquired expression of CCR5
(Fig. 3 C), a receptor for inflammatory chemokines ex-
pressed on Th1 effector cells (5). Together, these results
demonstrate that TCM cells that lack CXCR3 and CCR4
expression are nonpolarized precursors, whereas CXCR3 
and CCR4  TCM cells represent pre-Th1 and pre-Th2 cells
that become fully differentiated Th1 and Th2 effector cells
in response to homeostatic cytokines.
Figure 3. (A) Differentiation of TCM cell subsets in response to TCR or
cytokine stimulation. Purified CD4  T cell subsets were CFSE labeled
and stimulated with TSST-loaded DCs or with IL-7 and IL-15 in the
presence of neutralizing anti–IL-4 and anti–IL-12 antibodies. After 7 d,
cells were stimulated with PdBu and ionomycin, stained with APC-labeled
anti–IFN-  and PE-labeled anti–IL-4 antibodies, and cells of the same divi-
sion number were analyzed by flow cytometry. Unstimulated T cell subsets
were also analyzed ex vivo as control. Numbers indicate the percentage of
cells producing IFN-  or IL-4. One respresentative experiment out of
five is shown. (B and C) Modulation of homing receptor expression by
cytokine-stimulated CD4  memory T cell subsets. Purified CFSE-labeled
CD4  T cell subsets were stimulated with IL-7 and IL-15. TCM and TEM
cells in B were sorted for CXCR5, CCR7, and CD62L expression,
whereas in C they were sorted for CXCR5, CCR7, CXCR3, and
CCR4 expression as indicated. After 7 d, cells in division four were analyzed
for the expression of CXCR5, CCR7, and CD62L (B), or CXCR3,
CCR4, and CCR5 (C). One representative donor out of four is shown.Chemokine Receptor Expression Identifies Central Memory T Cell Subsets 730
To exclude a selective outgrowth of preexisting IFN- –
producing cells from CXCR3  TCM cells, we wished to
deplete cells with IFN- –producing capacity from cyto-
kine-stimulated cultures. To this aim it was necessary to
induce IFN-  production of Th1 cell–polarized memory
cells without activating TCR-dependent signaling. It is
well established that TCR-independent IFN-  production
of activated Th1 cells can be induced by inflammatory cy-
tokines IL-12 and IL-18 (44, 45). We found that produc-
tion of IFN-  by resting CD4  memory cells in response
to IL-12 and IL-18 required activation by IL-7 and IL-15,
was boosted by TNF- , and occurred with delayed kinet-
ics (Fig. 4 A). In contrast, IL-2 production was restricted
to TCR-stimulated cells (not depicted), confirming that
IFN-  production by cytokine-stimulated cells is TCR in-
dependent. Notably, TCR and cytokine stimulation in-
duced a similar fraction of cells to secrete IFN-  before cell
division (Fig. 4 A, note empty/filled symbols), and IFN- 
production was in both cases restricted to CXCR3  TCM
and TEM cells (Fig. 2 and not depicted). Thus, mature Th1
cell–polarized memory cells can be identified by IFN-  se-
cretion after either TCR or optimal cytokine activation.
Next, we induced IFN-  production by purified CFSE-
labeled CXCR3  TCM cells with cytokines, sorted undi-
vided IFN-  cells after 60 h, expanded them with IL-7 and
IL-15, and analyzed effector cytokine–producing capacities
of proliferating cells (Fig. 4 B). A large fraction of IFN-  
CXCR3  TCM cells differentiated under these conditions
and acquired the capacity to produce high levels of IFN- .
Sorting IFN-  cells after 72 h gave similar results (not de-
picted). In contrast, CCR4  TCM cells secreted IL-4 under
the same conditions, whereas IFN-   CXCR3  TCM cells
maintained high IFN-   production. We conclude that
CXCR3  TCM cells lacking IFN- –producing capacity be-
come Th1 effector cells after TCR-independent prolifera-
tion induced by cytokines.
Figure 4. (A) Kinetics and requirements of TCR- and cytokine-induced
IFN-  production. CFSE-labeled CD4  memory T cells were stimulated
for the indicated times with either anti-CD3 and anti-CD28 antibodies
(squares), or with TNF- , IL-12, and IL-18 in the absence (circles) or
presence (triangles) of IL-7 and IL-15. IFN-  production was analyzed by
intracellular staining. Empty symbols indicate conditions with undivided
cells, whereas filled symbols indicate conditions with dividing cells. The
mean percentage of IFN-   cells of three independent experiments is plot-
ted. (B) Cytokine-stimulated CXCR3  TCM cells lacking IFN- –producing
capacity become Th1 cell effector cells. Purified CFSE-labeled CXCR3 
TCM and CCR4  TCM cells were stimulated with IL-7, IL-15, TNF- ,
IL-12, and IL-18 for 60 h, and IFN- –secreting cells were purified by cell
sorting. IFN-   and IFN-   cells were then expanded for an additional
5 d with IL-7 and IL-15, briefly stimulated with PdBu and ionomycin, and
analyzed for IL-4 and IFN-  production by intracellular staining. One rep-
resentative donor out of three is shown.
Figure 5. Effects of polarizing cytokines on TCR- and
cytokine-induced differentiation. Purified CFSE-labeled
CD4  T cell subsets were stimulated with DC plus TSST
or IL-7 plus IL-15 in the absence or presence of IL-12 and
neutralizing anti–IL-4 antibody (Th1-condition) or IL-4
and neutralizing anti–IL-12 antibody (Th2-condition). After
7 d, cells were stimulated with PdBu and ionomycin and
cells of the same division number were analyzed for IFN- 
and IL-4 production by intracellular staining. The percent-
ages of INF-   cells (white bars), IL-4  cells (black bars),
and of cells producing both cytokines (gray bars) are repre-
sented. One representative experiment out of five with
different donors is shown.Rivino et al. 731
We then analyzed the effects of polarizing cytokines on
T cell differentiation induced by TCR agonists or homeo-
static cytokines. IL-4 and IL-12 induced differentiation
of TCR-stimulated CXCR5   and especially  / TCM
cells into IL-4– and IFN- –producing cells, respectively,
whereas they failed to modulate T cell differentiation in
IL-7 plus IL-15–activated T cells (Fig. 5, A and B). Under
the same conditions of TCR stimulation, IL-4 induced
CXCR3  T cells to produce the opposite cytokine IL-4
and promoted CCR4 expression, whereas IL-12 induced
CCR4  cells to produce IFN-  (Fig. 5 A) and up-regulate
CXCR3 (not depicted). Again, polarizing cytokines had
little effect on the extent of T cell differentiation in IL-7
plus IL-15–stimulated cells (compare Figs. 3 A and 5 B).
Similar results were obtained when IL-2 substituted for
IL-7 and IL-15, and in the absence or presence of TNF,
IL-6 and IL-10, DC-derived cytokines that strongly boost
proliferation of TCM cells in response to IL-7 and IL-15
(not depicted; reference 21). Together, these findings sug-
gest that flexibility of cytokine gene expression of human
memory T cells requires TCR triggering and polarizing
cytokines (13).
Proliferation History, In Vivo Turnover, and Recall Responses
of CD4  Memory T Cell Subsets. The proliferation his-
tory and in vivo turnover of the different memory T cell
subsets was then assessed by measuring the amounts of
TRECs and the spontaneous BrdU incorporation of ex
vivo–isolated cells. TRECs carrying a particular signal
joint sequence (37) were quantified by TaqMan PCR in T
cell subsets from five healthy donors (Fig. 6 A). As ex-
pected, CD4  CD45RA  naive T cells contained high
levels of TRECs, whereas B cells and T cell clones were
negative (not depicted). Compared with naive T cells,
CXCR5  TCM and CXCR5  TCM cells contained much
lower amounts of TRECs, whereas TEM cells contained
the lowest amount. Although there were considerable
quantitative differences among individual donors, these
data indicate that the different subsets of TCM cells have di-
vided to a similar extent.
To measure the spontaneous BrdU incorporation, freshly
isolated PBMCs were incubated with BrdU. CD4  T cells
were then purified and T cell subsets analyzed by intracellu-
lar staining with anti-BrdU antibodies. As shown in Fig. 6
B, CXCR5  TCM, CXCR3  TCM, and CCR4  TCM cells
spontaneously incorporated BrdU to a similar extent,
whereas TEM and especially  / TCM cells had a higher prolif-
eration rate and naive cells were below the detection limit.
These data indicate that memory T cells in different subsets
slowly turn over under steady-state conditions in vivo.
To investigate whether the different memory subsets
contained cells specific for recall antigens, T cell popula-
tions were isolated from smallpox- and/or tetanus-vacci-
nated donors and stimulated for 7 d with autologous
monocytes that were incubated with TT or with an extract
of CMV-derived proteins. To assess memory against small-
pox, monocytes were infected with a replication-deficient
VV. In these experiments, purified CFSE-labeled T cell
subsets and CFSE dilution were used to read out prolifera-
tion of pathogen-specific T cells. From eight donors ana-
lyzed, seven responded strongly to TT, whereas one donor
that had been boosted 20 yr ago had a low response (not
depicted). Five donors responded strongly to CMV, and
four of six donors that had also been vaccinated against
smallpox had a detectable response to VV. Responses to
autologous monocytes alone were undetectable or very
low (not depicted).
We analyzed the distribution of TT-, CMV-, and VV-
specific T cells among different memory subsets (one donor
Figure 6. Proliferation history, in vivo turnover, and recall responses of
CD4  memory T cell subsets. (A) Total CXCR5  TCM, CXCR5  TCM,
and TEM cells were analyzed for their single joint TREC content and
compared with naive cells from the same donor (naive cells: 100%). Bars
indicate the mean TREC levels in memory subsets of five different donors.
(B) Freshly isolated PBMCs were incubated with BrdU, CD4  T cells
were isolated, and BrdU incorporation was analyzed as a function of
CD45RA and chemokine receptor expression by flow cytometry. The
mean percentage of BrdU  cells in a given subset of four donors is shown.
(C) CD4  naive and memory subsets were sorted, labeled with CFSE,
and incubated with autologous monocytes that had either been infected
with VV or incubated with TT or an extract of CMV-derived proteins.
CFSE profiles of viable CD4  CD14  cells on day 7 of one representative
donor are shown. (D) Recall responses of memory subsets to TT of eight
different donors were assessed as described above, and the frequency of
TT-specific cells was calculated after 5 d. The frequency of TT-specific
cells in the indicted memory subsets of seven different TT-responsive donors
was plotted against the time of the last boost.Chemokine Receptor Expression Identifies Central Memory T Cell Subsets 732
responding to all three pathogens is shown in Fig. 6 C). In
all cases, pathogen-specific cells were detected in both the
TCM and TEM cell pools. TT-specific cells were undetect-
able among naive cells, but present in all memory subsets in
six of seven responsive donors. Conversely, CMV-specific
cells were largely restricted to CXCR3  TCM and TEM cells
in all five responsive donors, consistent with the notion
that CMV infection promotes a Th1 cell response (46).
Consistent with previous reports, VV-specific cells were
less frequent (47, 48), but were detectable in CXCR3 
TCM and TEM cells and, interestingly, in three of four do-
nors in CXCR5  TCM cells. Together, these results show
that all memory subsets contain cells specific for recall anti-
gens, and that the distribution of antigen-specific cells within
TCM cell subsets varies for different pathogens.
Next, we compared precursor frequencies of TT-specific
cells in different subsets in donors that had been boosted re-
cently or several years ago (Fig. 6 D). TT-specific cells
were relatively frequent among TEM cells ( 1:500) in all
donors. Conversely, CXCR5  TCM cells were less frequent
( 1:500), especially in donors that had not been boosted
for several years, possibly explaining the failure of previous
studies to detect TT-specific cells in this subset using thy-
midine incorporation (29, 31). Interestingly, the relative
distribution among CXCR3  TCM and CCR4  TCM cells
was highly variable, with some donors having higher num-
bers of CCR4  TCM cells and others containing predomi-
nantly CXCR3  TCM cells. These results indicate that TT-
specific T cells are present in high frequency in TEM cells,
even several years after vaccination, and are distributed in
different subsets of TCM cells.
Discussion
We have shown that the human CD4  TCM cell pool can
be subdivided into subsets of nonpolarized cells and pre-
Th1 and pre-Th2 cells based on chemokine receptor ex-
pression. These subsets have extensively divided in vivo
and contain cells specific for recall antigens and with self-
renewal capacity. Upon TCR-independent proliferation
induced by homeostatic cytokines, TCM cell subsets are
committed for different fates and become Th1, Th2, or re-
main nonpolarized cells, explaining how the quality of the
primary immune response could be maintained by TCM
cells in the absence of antigen.
Th cells expressing CXCR5 comprise CCR7  CD57 
follicular Th cells in tonsils (29, 30, 49), and nonpolarized
circulating CXCR5  TCM cells of unknown function and
specificity that might have a recent activation history (31).
Our results show that nonpolarized cells are present in both
CXCR5  and CXCR5  TCM cell subsets and lack CXCR3
and CCR4 expression. Using CFSE dilution we were fur-
ther able to show that CXCR5  TCM cells contained low
numbers of TT-specific cells even several years after vacci-
nation. Moreover, three of four smallpox-vaccinated,
responsive donors contained VV-specific cells at low
frequency in the CXCR5  TCM cell subset. Using quanti-
tative PCR, we found that CXCR5  TCM and CXCR5 
TCM cells contained comparable amounts of residual TRECs,
whereas TEM cells had slightly lower levels, suggesting that
TCM cell subsets had divided to a comparable extent (ap-
proximately seven times). However, because naive and
memory cells were identified by CD45 isoform expression
that is not a stable marker (25, 50), the number of divisions
performed by memory cells might be underestimated by
our analysis. Spontaneous BrdU uptake indicated that
CXCR5  TCM cells have an in vivo proliferation rate that
is comparable to that of other memory subsets. The rela-
tive small cell size and the absence of CD69 on BrdU 
cells suggest that this proliferation is driven by homeostatic
mechanisms rather than by antigen. Why  / TCM cells
have a higher turnover than other memory subsets is cur-
rently unclear. They might be particularly fit because they
combine a relatively high cytokine responsiveness with a
low susceptibility to apoptosis (51). Alternatively, they
might be preferentially located in cytokine-rich microen-
vironments or in proximity to DCs that boost proliferation
in response to IL-7 and IL-15 (21). In any case, these re-
sults show that all CD45RA  subsets, including CXCR5 
TCM cells, are memory cells that have extensively divided,
slowly turnover in vivo, and contain cells specific for recall
antigens.
Different viruses are known to induce CD8  memory
cells belonging preferentially to different subsets (52, 53).
Here we showed that although pathogen-specific CD4  T
cells are present in both the TCM and TEM cell pools, they
have characteristic distributions in TCM cell subsets, reflect-
ing the Th1/Th2 cell polarization induced by the patho-
gens or vaccinations. Thus, TT-specific cells were detected
in all subsets, consistent with the notion that vaccination
against tetanus induces a mixed Th1/Th2 cell response
(54). Conversely, CMV and VV promote Th1 cell polar-
ization (46, 47), and virus-specific cells were consequently
detected in CXCR3  TCM cells but not in CCR4 TCM
cells. In one donor, we were able to show that VV-specific
TEM cells were also CXCR3  (not depicted). Collectively,
these results suggest that immune responses generate het-
erogeneous populations of memory cells that belong to
different subsets and comprise a broad spectrum of differ-
entiation stages. The distribution between CXCR3  and
CCR4  subsets in the TCM and TEM cell pools might be
useful to monitor the quality of the memory response to
different pathogens.
Human memory T cells can be subdivided into CCR7 
TCM and CCR7  TEM cells with different effector func-
tions and homing potentials, suggesting a division of labor
between these two subsets (12). However, several recent
reports showed that antigen-experienced CCR7   cells
possess immediate effector functions (9, 32–35). Although
we identified here CCR7  memory cells with IFN- –
and IL-4–producing capacities as CXCR3  TCM and
CCR4  TCM cells, respectively, the following lines of evi-
dence suggest that these cells are not fully differentiated ef-
fectors: (a) they had a higher expansion potential than TEMRivino et al. 733
cells and most cells had retained CD27 and CD62L ex-
pression; (b) IFN-   production by CXCR3  TCM cells
was low and largely restricted to unconventional CCR7 
CD62L  cells; (c) although CCR4  TCM cells produced
some IL-4, production of IL-5, which acts on eosinophils
at peripheral sites of allergic inflammation, was limited to
TEM cells; (d) many CXCR3  TCM and CCR4  TCM cells
had retained flexibility to differentiate to Th2 and Th1
cells, respectively, upon antigenic stimulation in the pres-
ence of appropriate polarizing cytokines; and (e) upon
cytokine stimulation, they further differentiated, losing
CCR7 and CD62L and acquiring nonlymphoid homing
potential and high levels of effector functions. Together,
these findings are consistent with the notion that nonlym-
phoid tissue homing potential and effector cytokine–pro-
ducing capacities are progressively acquired upon T cell
differentiation and reside predominantly in the TEM cell
subset of the human CD4  memory cell pool (3). How-
ever, because effector functions and nonlymphoid homing
potentials are acquired in a stochastic manner (55), some
cells have characteristics that are intermediate between
TCM and TEM cells.
We previously proposed that cytokine-driven differenti-
ation of TCM cells might be a mechanism to replenish
short-lived TEM cells in the absence of antigen (21), but
how nonpolarized TCM cells could faithfully maintain po-
larized Th1 or Th2 effector cell populations remained un-
clear. A recent report showed that CD4 T cell priming
upon viral infection generated both short-lived effector
cells and long-lived precursors that lacked effector func-
tions, but spontaneously acquired IFN- –producing ca-
pacity when transferred into antigen-free hosts (26). We
showed here that CXCR3  TCM and CCR4  TCM cells in-
variably differentiated to CCR7  Th1 or Th2 effector cells
in an antigen-independent fashion, whereas CXCR5 
TCM cells remained nonpolarized and CCR7 . CXCR3
and CCR4 are preferentially induced under type 1
and type 2 priming conditions, respectively (6, 7), and
CXCR3  TCM and CCR4  TCM cells might therefore rep-
resent committed precursors of the Th1 and Th2 cell lin-
eage with the capacity to generate effector cells for
extended periods in the absence of antigen. Unlike cyto-
kines, TCR ligands can still instruct TCM cells to become
Th1 or Th2 cells in the presence of appropriate polarizing
cytokines (13). This differential flexibility might allow the
human immune system to mount qualitatively different re-
sponses in the case of cross-reactive antigens (56), or alter-
natively, to maintain the quality of the primary response
under homeostatic conditions.
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